Cargando…

Biomarkers in management of inflammatory bowel disease

In recent years the use of faecal and serologic biomarkers has been evaluated in the diagnosis and management of inflammatory bowel disease (IBD). Faecal calprotectin (FC) has been proposed as a surrogate marker for intestinal inflammation; elevated concentrations in IBD patients have been confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moniuszko, Andrzej, Wiśniewska, Anna, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2013
Materias:	Review Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027818/ https://www.ncbi.nlm.nih.gov/pubmed/24868269 http://dx.doi.org/10.5114/pg.2013.38728

Ejemplares similares

Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2017)

The effect of cyclic rifaximin therapy on symptoms of diverticular disease from the perspective of the gastroenterology outpatient clinic: a “real-life” study
por: Moniuszko, Andrzej, et al.
Publicado: (2017)

Assessment of sexual dysfunction in patients with inflammatory bowel disease
por: Szydlarska, Dorota, et al.
Publicado: (2019)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
por: Tulewicz-Marti, Edyta M., et al.
Publicado: (2021)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta Maria, et al.
Publicado: (2022)

Successful treatment of an enterovesical fistula due to Crohn’s disease with stem cell transplantation: a case report
por: Moniuszko, Andrzej, et al.
Publicado: (2018)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik
por: Pietrzak, Anna, et al.
Publicado: (2018)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

Assessment of the usefulness of imaging studies and biomarkers in the activity of Crohn’s disease
por: Piotrowicz, Grażyna, et al.
Publicado: (2020)

Use of functional magnetic resonance imaging in patients with irritable bowel syndrome and functional dyspepsia
por: Skrobisz, Katarzyna, et al.
Publicado: (2019)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Clostridium difficile infection in patients with inflammatory bowel disease
por: Czepiel, Jacek, et al.
Publicado: (2014)

A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
por: Łodyga, Michał, et al.
Publicado: (2022)

Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome
por: Lipiński, Michał, et al.
Publicado: (2017)

Biomarkers of Inflammatory Bowel Disease
por: Fengming, Yi, et al.
Publicado: (2014)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Awareness and Compliance with the Recommendations of Primary and Secondary Prevention of Cancer in Patients with Inflammatory Bowel Disease
por: Tulewicz-Marti, Edyta, et al.
Publicado: (2023)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
por: Sakurai, Toshiyuki, et al.
Publicado: (2023)

Health-related quality of life assessment among patients with inflammatory bowel diseases after surgery – review
por: Bączyk, Grażyna, et al.
Publicado: (2016)

Diet as therapeutic intervention in Crohn’s disease
por: Więcek, Martyna, et al.
Publicado: (2022)

Exocrine pancreatic insufficiency and causes of abdominal symptoms in diabetes patients
por: Kadaj-Lipka, Roland, et al.
Publicado: (2020)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2020)

Costs in inflammatory bowel diseases
por: Petryszyn, Paweł W., et al.
Publicado: (2016)

Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
por: Łodyga, Michał, et al.
Publicado: (2021)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017)

Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021)

The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
por: Alghoul, Zahra, et al.
Publicado: (2022)

Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis
por: Jaszczuk, Kamil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_godcknuc8kebtebqp6pes3nnvl